Litcius/Paper detail

Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients

Tiziano Barbui, Valerio De Stefano, Alessandra Carobbio, Alessandra Iurlo, Alberto Álvarez‐Larrán, Beatriz Cuevas, Francisca Ferrer‐Marín, Alessandro M. Vannucchi, Francesca Palandri, Claire Harrison, Hassan Sibai, Martin Grießhammer, Massimiliano Bonifacio, Elena Maria Elli, Chiara Trotti, Steffen Koschmieder, Giuseppe Carli, Giulia Benevolo, Jean‐Christophe Ianotto, Swati Goel, Anna Falanga, Silvia Betti, Daniele Cattaneo, Eduardo Arellano‐Rodrigo, Lara Mannelli, Nicola Vianelli, Andrew J. Doyle, Vikas Gupta, Kai Wille, Douglas Tremblay, John Mascarenhas

2021Leukemia59 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMyeloproliferative DisordersPolycythemia veraHematologyHematologic NeoplasmsMyelofibrosisInternal medicineCancerBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesCase Reports on Hematomas
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients | Litcius